The Next Step of Their Control Is Here …

Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.

4 simple steps to protect your privacy and money before it’s too late.

Bhaskar Chaudhuri net worth and biography

Bhaskar Chaudhuri Biography and Net Worth

Director of Arcutis Biotherapeutics

Dr. Chaudhuri has been an Operating Partner at Frazier Healthcare since 2011, focusing on investments in later-stage companies and in international opportunities. Prior to joining Frazier, he was President of Valeant Pharmaceuticals (currently Bausch Health), where he led Valeant’s international operations and business development activities. He joined Valeant through its acquisition of Dow Pharmaceutical Sciences, where he had been President and CEO. Dow focused on dermatology drug development and commercialization and was the source of multiple approved products. Before Dow, Bhaskar worked at Mylan Pharmaceuticals in several capacities including EVP of Scientific Affairs at Mylan subsidiary Bertek Pharmaceuticals, and as General Manager of the Dermatology Division. Earlier, he worked at Penederm as VP of R&D. In addition to Arcutis, he also serves on the board of Silvergate Pharmaceuticals (private) and Teligent (NASDAQ: TLGT). He also serves on the Advisory Board of the Johns Hopkins Berman Institute of Bioethics. He holds a Ph.D. from the University of Louisiana, a M.S. and a B.S. in Pharmacy from Jadavpur University, India.

What is Bhaskar Chaudhuri's net worth?: The estimated net worth of Bhaskar Chaudhuri is at least $7.18 million as of June 24th, 2021. Dr. Chaudhuri owns 848,146 shares of Arcutis Biotherapeutics stock worth more than $7,183,797 as of April 26th. This net worth estimate does not reflect any other assets that Dr. Chaudhuri may own. Additionally, Dr. Chaudhuri receives an annual salary of $59,670.00 as Director at Arcutis Biotherapeutics. Learn More about Bhaskar Chaudhuri's net worth.
How old is Bhaskar Chaudhuri?: Dr. Chaudhuri is currently 69 years old. There are 5 older executives and no younger executives at Arcutis Biotherapeutics. The oldest executive at Arcutis Biotherapeutics is Mr. John W. Smither CPA, Chief Financial Officer, who is 71 years old. Learn More on Bhaskar Chaudhuri's age.
What is Bhaskar Chaudhuri's salary?: As the Director of Arcutis Biotherapeutics, Inc., Dr. Chaudhuri earns $59,670.00 per year. There are 4 executives that earn more than Dr. Chaudhuri. The highest earning executive at Arcutis Biotherapeutics is Mr. Todd Franklin Watanabe M.A., President, CEO & Director, who commands a salary of $1,010,000.00 per year. Learn More on Bhaskar Chaudhuri's salary.
How do I contact Bhaskar Chaudhuri?: The corporate mailing address for Dr. Chaudhuri and other Arcutis Biotherapeutics executives is 2945 TOWNSGATE ROAD SUITE 110, WESTLAKE VILLAGE CA, 91361. Arcutis Biotherapeutics can also be reached via phone at 805-418-5006 and via email at [email protected]. Learn More on Bhaskar Chaudhuri's contact information.
Has Bhaskar Chaudhuri been buying or selling shares of Arcutis Biotherapeutics?: Bhaskar Chaudhuri has not been actively trading shares of Arcutis Biotherapeutics within the last three months. Most recently, Bhaskar Chaudhuri sold 729 shares of the business's stock in a transaction on Thursday, June 24th. The shares were sold at an average price of $27.50, for a transaction totalling $20,047.50. Following the completion of the sale, the director now directly owns 848,146 shares of the company's stock, valued at $23,324,015. Learn More on Bhaskar Chaudhuri's trading history.
Who are Arcutis Biotherapeutics' active insiders?: Arcutis Biotherapeutics' insider roster includes Patrick Burnett (Insider), Scott Burrows (CFO), Bhaskar Chaudhuri (Director), Patricia Turney (SVP), Todd Watanabe (CEO), and Howard Welgus (Director). Learn More on Arcutis Biotherapeutics' active insiders.
Are insiders buying or selling shares of Arcutis Biotherapeutics?: During the last year, Arcutis Biotherapeutics insiders bought shares 1 times. They purchased a total of 80,000 shares worth more than $200,000.00. During the last year, insiders at the sold shares 5 times. They sold a total of 10,370 shares worth more than $75,737.90. The most recent insider tranaction occured on March, 4th when insider Masaru Matsuda sold 3,760 shares worth more than $41,811.20. Insiders at Arcutis Biotherapeutics own 20.7% of the company. Learn More about insider trades at Arcutis Biotherapeutics.
Information on this page was last updated on 3/4/2024.

Bhaskar Chaudhuri Insider Trading History at Arcutis Biotherapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/24/2021	Sell	729	$27.50	$20,047.50	848,146
6/21/2021	Sell	2,516	$27.50	$69,190.00	848,875
4/20/2021	Sell	10,000	$28.06	$280,600.00	862,671
3/22/2021	Sell	10,000	$31.10	$311,000.00	876,383
2/1/2021	Sell	9,949	$33.25	$330,804.25	901,340
1/29/2021	Sell	51	$27.50	$1,402.50	901,340

Bhaskar Chaudhuri Buying and Selling Activity at Arcutis Biotherapeutics

Arcutis Biotherapeutics Company Overview

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical ZORYVE for the treatment of scalp and body psoriasis and seborrheic dermatitis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; ARQ-255, a topical JAK1 inhibitor for alopecia areata; and ARQ-234, a CD200R fusion protein for the treatment of moderate-to-severe atopic dermatitis. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.

Today's Range

Now: $8.47

$8.36

$8.85

50 Day Range

MA: $10.18

$8.59

$12.53

2 Week Range

Now: $8.47

$1.76

$15.21

Volume

2,163,559 shs

Average Volume

4,597,418 shs

Market Capitalization

$819.98 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.14

The Next Step of Their Control Is Here …

From Weiss Ratings | Ad

4 simple steps to protect your privacy and money before it’s too late.

Bhaskar Chaudhuri Biography and Net Worth

What is Bhaskar Chaudhuri's net worth?

How old is Bhaskar Chaudhuri?

What is Bhaskar Chaudhuri's salary?

How do I contact Bhaskar Chaudhuri?

Has Bhaskar Chaudhuri been buying or selling shares of Arcutis Biotherapeutics?

Who are Arcutis Biotherapeutics' active insiders?

Are insiders buying or selling shares of Arcutis Biotherapeutics?